Search research articles
Contact Us
Filters
Showing results (41-50 of 77) with videos related to
Page
of 8
Sort By:
British Journal of Haematology
|
July 18, 2008
Sustained response after reduced-intensity conditioning allogeneic stem cell transplantation for patients with relapsed peripheral T-cell non-Hodgkin lymphoma
Hugues de Lavallade, Philippe A Cassier, Reda Bouabdallah, et al.
Experimental Hematology
|
October 11, 2003
Bone marrow as stem cell source for allogeneic HLA-identical sibling transplantation following reduced-intensity preparative regimen
Catherine Faucher, Mohamad Mohty, Norbert Vey, et al.
British Journal of Haematology
|
September 19, 2006
Reduced-intensity conditioning allogeneic stem cell transplantation for patients with chemoresistant or relapsed follicular lymphoma
Hugues de Lavallade, Mohamad Mohty, Jean El-Cheikh, et al.
British Journal of Haematology
|
August 21, 2018
Prophylactic donor lymphocyte infusions after haploidentical haematopoietic stem cell transplantation for high risk haematological malignancies: a retrospective bicentric analysis of serial infusions of increasing doses of CD3<sup>+</sup> cells
Raphael Cauchois, Luca Castagna, Thomas Pagliardini, et al.
American Journal of Hematology
|
March 6, 2013
Long-term outcome after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with multiple myeloma
Jean El-Cheikh, Roberto Crocchiolo, Sabine Furst, et al.
Bone Marrow Transplantation
|
November 8, 2018
Post-transplantation cyclophosphamide-based haploidentical versus Atg-based unrelated donor allogeneic stem cell transplantation for patients younger than 60 years with hematological malignancies: a single-center experience of 209 patients
Thomas Pagliardini, Samia Harbi, Sabine Fürst, et al.
Mediterranean Journal of Hematology and Infectious Diseases
|
September 25, 2015
Comparison of Three Distinct Prophylactic Agents Against Invasive Fungal Infections in Patients Undergoing Haplo-identical Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide
Jean El-Cheikh, Roberto Crocchiolo, Andrea Vai, et al.
Experimental Hematology
|
February 2, 2002
Transient detection of beta-galactosidase activity in hematopoietic cells, following reinjection of retrovirally marked autologous blood progenitors in patients with breast or ovarian cancer receiving high-dose chemotherapy
Claude Bagnis, Christian Chabannon, Gwenaelle Gravis, et al.
Leukemia & Lymphoma
|
January 14, 2012
Allogeneic transplant for myeloma in the era of new drugs: have the outcomes improved?
Jean El-Cheikh, Roberto Crocchiolo, Jean-Marie Boher, et al.
Experimental Hematology
|
March 27, 2012
Lenalidomide plus donor-lymphocytes infusion after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with high-risk multiple myeloma
Jean El-Cheikh, Roberto Crocchiolo, Sabine Furst, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 77) with videos related to
Sort By:
Page
of 8
British Journal of Haematology
|
July 18, 2008
Sustained response after reduced-intensity conditioning allogeneic stem cell transplantation for patients with relapsed peripheral T-cell non-Hodgkin lymphoma
Hugues de Lavallade, Philippe A Cassier, Reda Bouabdallah, et al.
Experimental Hematology
|
October 11, 2003
Bone marrow as stem cell source for allogeneic HLA-identical sibling transplantation following reduced-intensity preparative regimen
Catherine Faucher, Mohamad Mohty, Norbert Vey, et al.
British Journal of Haematology
|
September 19, 2006
Reduced-intensity conditioning allogeneic stem cell transplantation for patients with chemoresistant or relapsed follicular lymphoma
Hugues de Lavallade, Mohamad Mohty, Jean El-Cheikh, et al.
British Journal of Haematology
|
August 21, 2018
Prophylactic donor lymphocyte infusions after haploidentical haematopoietic stem cell transplantation for high risk haematological malignancies: a retrospective bicentric analysis of serial infusions of increasing doses of CD3<sup>+</sup> cells
Raphael Cauchois, Luca Castagna, Thomas Pagliardini, et al.
American Journal of Hematology
|
March 6, 2013
Long-term outcome after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with multiple myeloma
Jean El-Cheikh, Roberto Crocchiolo, Sabine Furst, et al.
Bone Marrow Transplantation
|
November 8, 2018
Post-transplantation cyclophosphamide-based haploidentical versus Atg-based unrelated donor allogeneic stem cell transplantation for patients younger than 60 years with hematological malignancies: a single-center experience of 209 patients
Thomas Pagliardini, Samia Harbi, Sabine Fürst, et al.
Mediterranean Journal of Hematology and Infectious Diseases
|
September 25, 2015
Comparison of Three Distinct Prophylactic Agents Against Invasive Fungal Infections in Patients Undergoing Haplo-identical Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide
Jean El-Cheikh, Roberto Crocchiolo, Andrea Vai, et al.
Experimental Hematology
|
February 2, 2002
Transient detection of beta-galactosidase activity in hematopoietic cells, following reinjection of retrovirally marked autologous blood progenitors in patients with breast or ovarian cancer receiving high-dose chemotherapy
Claude Bagnis, Christian Chabannon, Gwenaelle Gravis, et al.
Leukemia & Lymphoma
|
January 14, 2012
Allogeneic transplant for myeloma in the era of new drugs: have the outcomes improved?
Jean El-Cheikh, Roberto Crocchiolo, Jean-Marie Boher, et al.
Experimental Hematology
|
March 27, 2012
Lenalidomide plus donor-lymphocytes infusion after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with high-risk multiple myeloma
Jean El-Cheikh, Roberto Crocchiolo, Sabine Furst, et al.
Page
of 8